Zoledronic Acid
Pharmaceutical-grade Zoledronic Acid monohydrate (CAS 118072-93-8), 98–102%, endotoxin-controlled, supplied wholesale by Zyntex to licensed producers. Potent bisphosphonate API for 4 mg and 5 mg intravenous infusions. CoA and SDS.
Description
Zoledronic Acid Product Overview
Zoledronic acid (C5H10N2O7P2) is a white crystalline powder, usually supplied as the monohydrate with a water content of about 6.2–7.2%; the anhydrous form has CAS 118072-92-7. It also contains an imidazole ring, which makes it one of the most potent bisphosphonates.
In addition, pharmaceutical companies use it in concentrates and ready-to-use solutions for intravenous infusion, typically 4 mg for oncology-related bone indications and 5 mg once yearly for osteoporosis. Unlike Teriparatide, which builds bone, it slows bone resorption. Similarly, related bone APIs in our range include Calcitriol.
Because it is infused, the API must meet strict limits for bacterial endotoxins and impurities. Zyntex therefore supplies it only to licensed pharmaceutical companies with sterile production capabilities.
Key Applications of Zoledronic Acid
Typical uses include, for example:
💉 Infusion Concentrates
API for 4 mg concentrates.
🦴 Osteoporosis Products
API for 5 mg once-yearly infusions.
🏥 Oncology Support
API for bone-related oncology products.
🔬 Generic Development
Development as well as reference material.
Zoledronic Acid Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Zoledronic Acid (Monohydrate) |
| CAS Number | 118072-93-8 (Anhydrous: 118072-92-7) |
| Assay / Purity (HPLC) | 98.0% – 102.0% (On Anhydrous Basis) |
| Appearance | White crystalline powder |
| Water Content (Monohydrate) | 6.2% – 7.2% |
| Bacterial Endotoxins | Strictly compliant with parenteral infusion limits |
| Documents | CoA as well as SDS with every lot |
⚠️ Safety & Handling: Pharmacologically active substance that may cause serious eye irritation and damage to organs through prolonged exposure. Avoid inhalation of dust and contact, and also wear gloves, eye protection and respiratory protection. Store in tightly closed containers in a cool, dry place. Always consult the Safety Data Sheet (SDS), because it contains the full classification and handling instructions.
Frequently Asked Questions
Which strengths are common?
Mainly 4 mg infusion concentrates for oncology-related bone indications as well as 5 mg once-yearly infusions for osteoporosis.
How does it differ from teriparatide?
It slows bone resorption, whereas teriparatide stimulates new bone formation.
How can I get a price and documents?
Prices depend on quantity, packaging and destination, so please contact us with your required volume. We then send a quotation together with the CoA and SDS.
